SOX9, which can be directly induced in HBV-infected human hepatoma cells (Yang et al., 2020) has been identified as a risk factor for cirrhosis and HCC (Chen et al., 2021; Damrauer et al., 2021). Here, SOX9 is linked to hepatocellular carcinoma.